期刊文献+

脑血管病与原发性醛固酮增多症的研究进展 被引量:1

Research progress on cerebrovascular disease and primary aldosteronism
下载PDF
导出
摘要 脑血管病是指由于一根或多根脑血管病变引起的脑部短暂性或永久性功能障碍。高血压、糖尿病、高脂血症、房颤、缺乏锻炼等是脑血管病的危险因素。随着人们对其的了解深入,发现了很多原发性醛固酮增多症(primary aldosteronism,PA)患者表现出神经系统的症状和体征。越来越多的研究开始关注原发性醛固酮增多症对神经系统,尤其脑血管疾病的影响。由于PA不是脑血管病常见病因,临床易漏诊。 Cerebrovascular disease refers to transient or permanent dysfunction of the brain caused by one or more cerebro vascular diseases. Hypertension, diabetes, hyperlipidemia, atrial fibrillation, and lack of exercise are risk factors for cerebrovascular disease. As people learn more about it,many patients with primary aldosteronism (PA) have been found to exhibit symptoms and signs of the nervous system. More and more research is beginning to focus on the effects of primary aldosteronism on the nervous system, especially cerebrovascular disease. Because PA is not a common cause of cerebrovascular disease, clinical diagnosis is missed.
作者 张首龙 王诺 邓本强 ZHANG ShouZong;WANG Nuo;DENG Benqiang(Cerebrovascular Disease Center,Changhai Hospital,Naval Military Medical University,Shanghai 200433,China)
出处 《中国实用神经疾病杂志》 2018年第15期1625-1628,共4页 Chinese Journal of Practical Nervous Diseases
基金 上海市科技创新行动计划重点项目(14401970304)
关键词 原发性醛固酮增多症 脑血管病 醛固酮 漏诊 相关性分析 Primary aldosteronism Cerebrovascular disease Aldosterone Missed diagnosis Correlation analysis
  • 相关文献

参考文献1

二级参考文献20

  • 1张炜,汤正义,吴景程,王卫庆,宁光.静脉盐水负荷试验在原发性醛固酮增多症诊断中的应用[J].上海交通大学学报(医学版),2007,27(6):703-705. 被引量:22
  • 2Mosso L, Carvajal C, Gonzdlez A, et al. Primary aldosteronism and hypertensive disease [ J ]. Hypertension, 2003,42 ( 2 ) : 161 -165. DOI : 10.1161/01. HYP. 0000079505. 25750. l 1.
  • 3Calhoun DA. Is there an unrecognized epidemic of primary aldosteronism? Pro [ J ]. Hypertension, 2007, 50 ( 3 ) : 447-453 ; discussion 447-453. DOI: 10. l l61/HYPERTENSIONAHA. 106. 086116.
  • 4Loh KC, Koay ES, Khaw MC, et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore [ J ]. J Clin Eudocrinol Metab, 2000,85 ( 8 ) : 2854-2859. DOI: 10. 1210/ jcem. 85.8. 6752.
  • 5Sang X, Jiang Y, Wang W, et al. Prevalence of and risk factors forprimary aldosteronism among patients with resistant hypertension in China[J]. J Hypertens, 2013,31 (7) : 1465-1471 ; discussion 1471- 1472. DOI: 10. 1097/HJH. 0b013e328360ddf6.
  • 6Di MA, Petramala L, Cotesta D, et al. Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism [ J ]. J Renin Angiotensin Aldosterone Syst, 2010, 11 (3) : 165-172. DOI : 10.1177/1470320310366581.
  • 7Hiramatsu K, Yamada T, Yukimura Y, et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients[ J]. Arch Intern Med, 1981, 141(12) :1589-1593.
  • 8Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab, 2008, 93(9) :3266-3281. DOI: 10. 1210/jc. 2008-0104.
  • 9Ahmed AH, Cowley D, Wolley M, et al. Seated saline suppression testing for the diagnosis of primary aldosteronism : a preliminary study [J]. J Clin Endocrinol Metab, 2014, 99 ( 8 ) : 2745-2753. DOI: 10. 1210/jc. 2014-1153.
  • 10Rossi GP, Auchus R J, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism[ J]. Hypertension, 2014, 63 ( 1 ) : 151-160. DOI: 10.1161/HYPERTENSIONAHA. 113. 02097.

共引文献161

同被引文献29

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部